Healthcare

Renal Biomarkers Market Analysis, Outlook, Size, Growth And Trends 2024-2033

The renal biomarkers global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Renal Biomarkers Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –

The renal biomarkers market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases.

The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to personalized medicine and targeted therapies, integration of biomarker testing into routine clinical practice, emerging markets in asia and latin america, non-invasive biomarker testing methods, continuous monitoring with wearable devices. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, ai and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention.

Order your report now for swift delivery @

https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Scope Of Renal Biomarkers Market

The Business Research Company’s reports encompass a wide range of information, including:

Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
Drivers: Examination of the key factors propelling market growth.
Trends: Identification of emerging trends and patterns shaping the market landscape.
Key Segments: Breakdown of the market into its primary segments and their respective performance.
Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
Macro Economic Factors: Assessment of broader economic elements impacting the market.

Renal Biomarkers Market Overview

Market Drivers –

The rise in geriatric and paediatric renal patients is expected to propel the growth of the renal biomarkers market going forward. Geriatric renal patients refer to the elderly patients aged above 70 years with advanced chronic kidney disease (CKD). However, paediatric renal patients refer to the patients who are commonly diagnosed with renal disorder during childhood and young adulthood. Renal biomarkers help to evaluate the severity of renal injury in geriatric and paediatric renal patients. For instance, in March 2021, according to the data published by the Centers for Disease Control and Prevention, a US-based government administrative agency, nearly 37 million adults in the US have chronic renal disease and it is more prevalent in adults 65 years of age and older (38%). Therefore, the rise in geriatric and paediatric renal patients is driving the growth of the renal biomarkers market.

The renal biomarkers market covered in this report is segmented –

1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types

2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)

3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare

4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Get an inside scoop of the renal biomarkers market, Request now for Sample Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

Regional Insights –

North America was the largest region in the renal biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies –

Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Eli Lilly and Company, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.

Table of Contents

Executive Summary
Renal Biomarkers Market Characteristics
Renal Biomarkers Market Trends And Strategies
Renal Biomarkers Market – Macro Economic Scenario
Global Renal Biomarkers Market Size and Growth

……………

Key Mergers And Acquisitions In The Renal Biomarkers Market
Renal Biomarkers Market Future Outlook and Potential Analysis
Appendix

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Renal Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Renal Biomarkers Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Renal Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

………….

Table 75: Abbott Laboratories Financial Performance

Table 76: BioPorto Diagnostics A/S Financial Performance

Table 77: Roche Holding AG Financial Performance

Table 78: Thermo Fisher Scientific Financial Performance

Table 79: bioMérieux SA Financial Performance

Read Related Reports:

https://goodprnews.com/electrical-and-electronics-ceramics-market-trend/

https://topprnews.com/enteric-disease-testing-market-trends/

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/